Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma

Abstract Ginsenoside Rh2 (Rh2) is one of the main bioactive ginsenosides that act as a natural antitumor drug. However, the clinical application of Rh2 is limited by its low solubility in water. In this study, a novel ginsenoside Rh2 pH-sensitive liposome was constructed for targeted liver cancer th...

Full description

Saved in:
Bibliographic Details
Main Authors: Fengkai Sun, Jinkun Liu, Shuai Gao, Mingchen Zhang, Xiaoyan Sun, Yanan Tian, Shengchun Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-15236-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849345112666013696
author Fengkai Sun
Jinkun Liu
Shuai Gao
Mingchen Zhang
Xiaoyan Sun
Yanan Tian
Shengchun Wang
author_facet Fengkai Sun
Jinkun Liu
Shuai Gao
Mingchen Zhang
Xiaoyan Sun
Yanan Tian
Shengchun Wang
author_sort Fengkai Sun
collection DOAJ
description Abstract Ginsenoside Rh2 (Rh2) is one of the main bioactive ginsenosides that act as a natural antitumor drug. However, the clinical application of Rh2 is limited by its low solubility in water. In this study, a novel ginsenoside Rh2 pH-sensitive liposome was constructed for targeted liver cancer therapy. Rh2 nanoparticles (NPs) exhibited an acid responsive mode, where cumulative release increased with the decrease in pH value. Rh2 and Rh2 NPs showed a dose-dependent inhibitory effect on Huh7 and MHCC97H cells. Rh2 and Rh2 NPs significantly inhibited tumor cell proliferation, migration, invasion and epithelial-mesenchymal transition, and promoted cell apoptosis and immunogenic cell death. Moreover, compared to Rh2 monomers, the Rh2 NPs exhibited improved antitumor effects in vitro. In vivo antitumor efficacy studies indicated that the Rh2 and Rh2 NPs significantly inhibited tumor growth, thereby decreasing tumor volume and weight at the end of the experiment compared with that in the control mice. Furthermore, Rh2 NPs had a more significant inhibitory effect on tumor growth compared with Rh2 monomers. Rh2 NPs might serve as a novel drug delivery system to enhance the antitumor potentials of Rh2 for effective liver cancer therapy.
format Article
id doaj-art-8abaf4508e554cb9ba0570b17eff4d68
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-8abaf4508e554cb9ba0570b17eff4d682025-08-20T03:42:31ZengNature PortfolioScientific Reports2045-23222025-08-0115111310.1038/s41598-025-15236-wNanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinomaFengkai Sun0Jinkun Liu1Shuai Gao2Mingchen Zhang3Xiaoyan Sun4Yanan Tian5Shengchun Wang6Postdoctoral Research Station, Shandong University of Traditional Chinese MedicineShandong Anran Nanometer Industry Development Co., LtdShandong Anran Nanometer Industry Development Co., LtdShandong Anran Nanometer Industry Development Co., LtdDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityDepartment of Acupuncture, Physiotherapy and Rehabilitation, Shandong Provincial Hospital Affiliated to Shandong First Medical UniversityAbstract Ginsenoside Rh2 (Rh2) is one of the main bioactive ginsenosides that act as a natural antitumor drug. However, the clinical application of Rh2 is limited by its low solubility in water. In this study, a novel ginsenoside Rh2 pH-sensitive liposome was constructed for targeted liver cancer therapy. Rh2 nanoparticles (NPs) exhibited an acid responsive mode, where cumulative release increased with the decrease in pH value. Rh2 and Rh2 NPs showed a dose-dependent inhibitory effect on Huh7 and MHCC97H cells. Rh2 and Rh2 NPs significantly inhibited tumor cell proliferation, migration, invasion and epithelial-mesenchymal transition, and promoted cell apoptosis and immunogenic cell death. Moreover, compared to Rh2 monomers, the Rh2 NPs exhibited improved antitumor effects in vitro. In vivo antitumor efficacy studies indicated that the Rh2 and Rh2 NPs significantly inhibited tumor growth, thereby decreasing tumor volume and weight at the end of the experiment compared with that in the control mice. Furthermore, Rh2 NPs had a more significant inhibitory effect on tumor growth compared with Rh2 monomers. Rh2 NPs might serve as a novel drug delivery system to enhance the antitumor potentials of Rh2 for effective liver cancer therapy.https://doi.org/10.1038/s41598-025-15236-wGinsenoside Rh2PH-sensitive liposomeNanoparticleAntitumorHepatocellular carcinoma
spellingShingle Fengkai Sun
Jinkun Liu
Shuai Gao
Mingchen Zhang
Xiaoyan Sun
Yanan Tian
Shengchun Wang
Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
Scientific Reports
Ginsenoside Rh2
PH-sensitive liposome
Nanoparticle
Antitumor
Hepatocellular carcinoma
title Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
title_full Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
title_fullStr Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
title_full_unstemmed Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
title_short Nanoparticle conjugation of ginsenoside Rh2 enhanced antitumor efficacy on hepatocellular carcinoma
title_sort nanoparticle conjugation of ginsenoside rh2 enhanced antitumor efficacy on hepatocellular carcinoma
topic Ginsenoside Rh2
PH-sensitive liposome
Nanoparticle
Antitumor
Hepatocellular carcinoma
url https://doi.org/10.1038/s41598-025-15236-w
work_keys_str_mv AT fengkaisun nanoparticleconjugationofginsenosiderh2enhancedantitumorefficacyonhepatocellularcarcinoma
AT jinkunliu nanoparticleconjugationofginsenosiderh2enhancedantitumorefficacyonhepatocellularcarcinoma
AT shuaigao nanoparticleconjugationofginsenosiderh2enhancedantitumorefficacyonhepatocellularcarcinoma
AT mingchenzhang nanoparticleconjugationofginsenosiderh2enhancedantitumorefficacyonhepatocellularcarcinoma
AT xiaoyansun nanoparticleconjugationofginsenosiderh2enhancedantitumorefficacyonhepatocellularcarcinoma
AT yanantian nanoparticleconjugationofginsenosiderh2enhancedantitumorefficacyonhepatocellularcarcinoma
AT shengchunwang nanoparticleconjugationofginsenosiderh2enhancedantitumorefficacyonhepatocellularcarcinoma